Standex International Corporation
SXIStandex International Corporation's price has outrun its earnings. +76.4% in a year against EPS −24.4% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +76.4% in a year while annual EPS moved −24.4% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (37 weeks in) while the P/E sits at the 75th percentile of its own 4-year range. Underneath, the last four quarters read improving — profit +250.0% year on year, and 93% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Standex International Corporation trades at $294, in a confirmed uptrend and 37 weeks into that stage. That is +12.7% against its own 200-day average. It sits at 69% of a 52-week range of $188 to $341. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks.
Today the stock is in a confirmed uptrend — week 37 of stage 2. At $294 it trades +12.7% versus its 200-day average and sits at 69% of its 52-week range ($188–$341).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +248% while the S&P 500 moved +248% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 9 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 75th percentile of its own range.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Standex International Corporation trades at 35.8× P/E, at the pricey end of its own range (75th percentile). Its long-run median P/E is 27.1×, measured across 4.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 35.8× is at the pricey end of its own range (75th percentile), against a long-run median of 27.1× measured over 4.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −24.4% against a +76.4% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +26.8%/yr price move, ~−11.1%/yr came from earnings growth and ~+37.9 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Standex International Corporation reads as turning around on its fundamental arc. Turning around — EPS growth swung from −48.0% at the trough to +62.1%, a 2-quarter improving streak, ROCE lifting at 14.0%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +9.7% | +2.2% | — | — |
| Profit | −14.3% | +0.0% | — | — |
| EPS | −24.4% | −2.8% | — | — |
| Stock price | +76.4% | +26.8% | +26.1% | +12.7% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
No sector-relative score — Standex International Corporation is not among the largest members shown in this industry comparison for Specialty Industrial Machinery.
The score is a rank WITHIN a peer set: every metric is scored by percentile against the other members. Without the peer set there is no score to state, so none is invented here.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Standex International Corporation reported $0.2 B of revenue in the Mar 26 quarter, +4.8% year on year. That is the 6th straight quarter of year-on-year growth. Over 4 years it has compounded at 4.6% a year. The last full year, FY25, came in at $0.8 B. The last four reported quarters add to $0.9 B.
Standex International Corporation reported $0.2 B of revenue in the Mar 26 quarter, +4.8% year on year. That is the 6th straight quarter of year-on-year growth. Over 4 years it has compounded at 4.6% a year. The last full year, FY25, came in at $0.8 B. The last four reported quarters add to $0.9 B.
FY25 revenue came in at $0.8 B (+9.7% on the year), capping 4 years at 4.6% compound. The latest quarter (Mar 26) printed $0.2 B, +4.8% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +18.0% growth against the decade's 4.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +17.3% over the last 4 quarters against +9.8%/yr over the last 8 — accelerating; TTM profit +116.7% vs +27.5%/yr — accelerating.
→ Revenue grew — did margins hold as it scaled? Next: 13.6% this quarter (−0.7 pp YoY).
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Standex International Corporation's operating margin is 13.6% in the Mar 26 quarter, −0.7 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 9.1% to 23.0%. The current quarter sits inside that band.
Standex International Corporation's operating margin is 13.6% in the Mar 26 quarter, −0.7 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 9.1% to 23.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 13.6%, −0.7 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 9.1%–23.0%.
🚨 Why the margin moved: operating margin went −0.7 pp year on year while gross margin went +2.8 pp — the loss came mostly from the gross line: input costs and pricing.
→ Margins slipped — did that reach the bottom line? Next: profit +250.0% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Standex International Corporation earned $0.1 B of net profit in the Mar 26 quarter, +250.0% year on year. Full-year FY25 profit was $0.1 B. The 4-year compound rate is 10.7%. That is 31.8% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.
Standex International Corporation earned $0.1 B of net profit in the Mar 26 quarter, +250.0% year on year. Full-year FY25 profit was $0.1 B. The 4-year compound rate is 10.7%. That is 31.8% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.
Mar 26 profit was $0.1 B, +250.0% year on year. On the full year, FY25 printed $0.1 B (−14.3%), and the 4-year compound rate is 10.7%.
Why profit moved: revenue contributed +4.8% and the margin −0.7 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +83.3% vs revenue +18.0%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
→ Profit rose — but did the cash follow? Next: 93% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 93% of Standex International Corporation's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.1 B of operating cash against $0.1 B of profit. After $0.0 B of capital spending, $0.0 B was left as free cash.
FY25: operating cash of $0.1 B against reported profit of $0.1 B, leaving free cash of $0.0 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 93% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
→ So follow the cash to where it goes. Next: $0.0 B of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Standex International Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROE is 16% and the ROIC − WACC spread is +0.2 pp.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Standex International Corporation earns a ROE of 8% in FY25. That is up from a trough of 8% in FY21. Return on invested capital clears the cost of that capital by +0.2 percentage points, so growth here adds value rather than only size. The wiring behind it is 7.6% net margin on 0.50× asset turns.
FY25 ROE is 8%, recovered from a FY21 trough of 8% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 7.6% net margin × 0.50× asset turns × 2.12× balance-sheet leverage ≈ 8.1% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 9.5% − 9.3% = a +0.2 pp spread. The 9.3% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.65.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Standex International Corporation paid $1.32 per share over the last four reported quarters, up 6.3% on a year ago. The most recent declaration was $0.34 for Mar 26. Against the current price of $294 that is a trailing yield of 0.45%, measured on dividends already paid rather than on a forecast.
Standex International Corporation paid $1.32 per share over the last four reported quarters, up 6.3% on a year ago. The most recent declaration was $0.34 for Mar 26. Against the current price of $294 that is a trailing yield of 0.45%, measured on dividends already paid rather than on a forecast.
Standex International Corporation paid $1.32 per share across the last four reported quarters, most recently $0.34 for Mar 26. That is up 6.3% against the same quarter a year earlier. Against the current price of $294 the trailing twelve months work out to 0.45% — trailing dividends measured against today's price, not a forward estimate.
→ A payout is cash leaving the business. Next: what the balance sheet looks like behind it.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Standex International Corporation carries total debt of $0.5 B against shareholder equity of $0.8 B as of Mar 26, a debt-to-equity of 0.64. On the annual view that ratio went from 0.45 in FY21 to 0.80 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $0.5 B against shareholder equity of $0.8 B — a debt-to-equity of 0.64. On the annual view, debt-to-equity went from 0.45 (FY21) to 0.80 (FY25). Read the returns on this page with that leverage in mind.
→ Who owns this, and are they adding or leaving? Next: short interest is 6.1% of the float.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
6.1% of Standex International Corporation's tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 3.1 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 6.1% of the float is sold short, and at typical trading volumes it would take about 3.1 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Standex International Corporation: the Z-score reads 4.30. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 4.30 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 4.30.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Standex International Corporation this page | 35.8× | $4B | Turning around | |||
| GE Vernova Inc. | 27.0× | $251B | No read | |||
| Eaton Corporation plc | 37.8× | $150B | Consistent | |||
| Parker-Hannifin Corporation | 36.6× | $125B | Mixed | |||
| Cummins Inc. | 34.4× | $89B | Topping out | |||
| Emerson Electric Co. | 35.1× | $85B | Improving | |||
| Illinois Tool Works Inc. | 25.8× | $85B | Deteriorating | |||
| AMETEK, Inc. | 36.5× | $55B | Mixed | |||
| Rockwell Automation, Inc. | 48.9× | $52B | Improving | |||
| Ingersoll Rand Inc. | 58.6× | $34B | Deteriorating | |||
| Xylem Inc. | 29.7× | $30B | Mixed | |||
| Otis Worldwide Corporation | 18.9× | $28B | Deteriorating | |||
| Dover Corporation | 24.4× | $27B | Improving | |||
| Symbotic Inc. | — | $26B | No read | |||
| ITT Inc. | 35.4× | $18B | Deteriorating | |||
| Nordson Corporation | 32.3× | $17B | Turning around | |||
| IDEX Corporation | 33.2× | $17B | Turning around | |||
| Regal Rexnord Corporation | 47.2× | $14B | Improving | |||
| Graco Inc. | 25.9× | $13B | Mixed | |||
| Crane Company | 41.5× | $13B | Topping out | |||
| Watts Water Technologies, Inc. | 31.7× | $12B | Consistent | |||
| Generac Holdings Inc. | 61.1× | $12B | Deteriorating | |||
| Donaldson Company, Inc. | 25.7× | $11B | Turning around | |||
| Pentair plc | 16.8× | $11B | Mixed | |||
| Chart Industries, Inc. | — | $10B | Deteriorating | |||
| Flowserve Corporation | 27.0× | $9B | Consistent | |||
| A. O. Smith Corporation | 17.1× | $9B | Mixed | |||
| JBT Marel Corporation | 45.4× | $8B | Deteriorating | |||
| Gates Industrial Corporation plc | 27.8× | $7B | Improving | |||
| Enpro Inc. | 152.7× | $7B | Deteriorating | |||
| The Middleby Corporation | 18.5× | $6B | Deteriorating | |||
| CSW Industrials, Inc. | 44.6× | $5B | Deteriorating | |||
| Franklin Electric Co., Inc. | 31.6× | $5B | Deteriorating | |||
| Mirion Technologies, Inc. | 189.9× | $4B | No read | |||
| Mueller Water Products, Inc. | 19.6× | $4B | Mixed | |||
| Kadant Inc. | 35.9× | $4B | Turning around | |||
| Crane NXT, Co. | 24.5× | $3B | Deteriorating | |||
| NuScale Power Corporation | — | $3B | No read | |||
| ERock, Inc. | — | $3B | — | — | — | — |
| ATS Corporation | 51.6× | $3B | Deteriorating |
Frequently asked questions
What is Standex International Corporation's stock price today?
Standex International Corporation trades at $294, +76.4% over the past year. The company is valued at $4.0 B. The stock sits at 69% of its 52-week range of $188–$341, +12.7% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 37 weeks in. — as of 29 July 2026.
What were Standex International Corporation's latest quarterly results?
Standex International Corporation reported revenue of $0.2 B and net profit of $0.1 B for the Mar 26 quarter. Revenue rose 4.8% and profit rose 250.0% year on year. Earnings per share were $5.55. The operating margin was 13.6%, 0.7 pp lower than a year earlier. — as of 29 July 2026.
What is Standex International Corporation's revenue?
Standex International Corporation reported revenue of $0.2 B in the Mar 26 quarter, +4.8% year on year. For the full FY25 fiscal year, revenue was $0.8 B (+9.7%). Over the last 4 years revenue compounded at 4.6% a year. — as of 29 July 2026.
What is Standex International Corporation's profit?
Standex International Corporation earned $0.1 B of net profit in the Mar 26 quarter, +250.0% year on year. Full-year FY25 profit was $0.1 B. The operating margin ran 13.6% in the latest quarter. — as of 29 July 2026.
What is Standex International Corporation's market cap?
Standex International Corporation's market capitalisation is $4.0 B at a stock price of $294. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.
What is Standex International Corporation's P/E ratio?
Standex International Corporation trades at a P/E of 35.8×, at the 75th percentile of its own 4-year range, against a long-run median of 27.1×. This is a comparison with the stock's own history, not a value call — as of 29 July 2026.
Does Standex International Corporation pay a dividend?
Yes — Standex International Corporation declared $0.34 per share for Mar 26, and $1.32 per share across the last four reported quarters. The latest quarter is up 6.3% on the same quarter a year earlier. — as of 29 July 2026.
What is Standex International Corporation's dividend per share?
Standex International Corporation's most recently declared dividend is $0.34 per share for Mar 26, giving $1.32 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 29 July 2026.
What is Standex International Corporation's dividend yield?
Standex International Corporation's trailing dividend yield is 0.45%: $1.32 declared per share across the last four reported quarters, against a share price of $294. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 29 July 2026.
Is Standex International Corporation overvalued?
On its own history, Standex International Corporation looks expensive against its own history: its P/E of 35.8× sits at the 75th percentile of its 4-year range (long-run median 27.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 29 July 2026.
Is Standex International Corporation growing?
Yes — Standex International Corporation is growing: latest-quarter revenue +4.8% year on year, profit +250.0%, and the margin −0.7 pp at 13.6%. The 4-year compound rates are 4.6% (revenue) and 10.7% (profit). The earnings engine currently reads: improving — as of 29 July 2026.
How is Standex International Corporation performing?
Standex International Corporation is in a confirmed uptrend, 37 weeks in. Its latest quarter's revenue rose 4.8% and profit rose 250.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 9 weeks. This describes what the data did, not a rating. — as of 29 July 2026.
What stage is Standex International Corporation in?
Turning around — EPS growth swung from −48.0% at the trough to +62.1%, a 2-quarter improving streak, ROCE lifting at 14.0%. The read comes from the last 12 quarters of growth (revenue growth +17.3% latest, profit growth +116.7% latest, eps growth +62.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 29 July 2026.
Is Standex International Corporation in an uptrend?
Yes — the price is in a confirmed uptrend (week 37 of stage 2), trading +12.7% versus its 200-day average and at 69% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 29 July 2026.
Is Standex International Corporation beating the market?
On recent form, yes — Standex International Corporation has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +248% against the S&P 500's +248% — ahead of the index over the full window. — as of 29 July 2026.
Will Standex International Corporation's stock price go up?
This page publishes no price forecast for Standex International Corporation. What it measures instead: the stock price is $294, the price is in a confirmed uptrend 37 weeks in. Its P/E of 35.8× sits at the 75th percentile of its own 4-year range. — as of 29 July 2026.
Is the market betting against Standex International Corporation?
Somewhat — short interest is 6.1% of Standex International Corporation's tradable float, about 3.1 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 29 July 2026.
Does Standex International Corporation have too much debt?
It is moderate — Standex International Corporation's debt-to-equity is 0.65. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 29 July 2026.
What is Standex International Corporation's capex?
Standex International Corporation spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 29 July 2026.
What is Standex International Corporation's cash flow?
Standex International Corporation generated $0.1 B of operating cash flow in FY25 and $0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.1 B, so operating cash ran ahead of profit. — as of 29 July 2026.
Is Standex International Corporation's profit real cash?
Yes — over the last 3 fiscal years, 93% of Standex International Corporation's reported profit arrived as operating cash. In FY25, operating cash was $0.1 B against reported profit of $0.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 29 July 2026.
How financially safe is Standex International Corporation?
On the balance sheet, the Z-score reads 4.30 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 29 July 2026.
Where is Standex International Corporation in its business cycle?
Standex International Corporation's FY25 operating margin was 11.4%, against a 5-year band of 9.1%–23.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 13.6%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.
What could break the Standex International Corporation story?
The sharpest disagreement: the price moved +76.4% in a year while annual EPS moved −24.4% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.
Is Standex International Corporation a stock worth studying right now?
This is not investment advice. The machine read: Standex International Corporation's price has outrun its earnings. +76.4% in a year against EPS −24.4% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.